Welcome to our dedicated page for Macy's SEC filings (Ticker: M), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Macy’s, Inc. filings document the public-company disclosures of a retail operator with the Macy’s, Bloomingdale’s and Bluemercury nameplates. Recent Form 8-K reports cover operating results, financial condition, cash flows, non-GAAP measures such as adjusted EBITDA and adjusted earnings, and updates to financial disclosure metrics tied to the company’s go-forward business and comparable-sales reporting.
The company’s proxy and other current reports also describe shareholder meeting matters, board composition, director elections, executive compensation, compensatory arrangements and governance changes. These filings frame Macy’s capital-market reporting around retail performance, disclosure controls, governance structure and shareholder voting processes.
Richard Clark, a director of Macy's, Inc. (M), reported the conversion of phantom stock units into 1,971 shares of common stock on 09/30/2025. The Form 4 shows these were recorded as an acquisition (A) of 1,971 shares at an average unit value of $13.9573, representing the quarterly average value of the granted stock units.
The filing notes the phantom units convert 1-for-1 to common stock and that settlement of the units in actual shares will occur upon the reporting person's termination from the board. The Form 4 was signed by an attorney-in-fact on behalf of Richard Clark on 10/01/2025.
Danielle L. Kirgan, EVP and Chief HR Officer of Macy's, Inc. (M), reported a sale of 100,000 shares of Macy's common stock on 09/17/2025 at a reported price of $17.75 per share. After the transaction she is shown as beneficially owning 136,161 shares directly. The Form 4 was signed by an attorney-in-fact on 09/18/2025.
Macy's, Inc. Form 144 reports a proposed sale of 50,000 shares of common stock to be executed on 09/18/2025 through Charles Schwab, with an aggregate market value of $870,000.00. The filing shows these 50,000 shares were acquired in March 2023 through restricted/performance stock vesting. The notice also discloses sales by the same person in the prior three months totaling 250,000 shares for gross proceeds of $4,379,527.03 (sales on 09/05/2025, 09/11/2025, and 09/17/2025). The issuer's outstanding shares are listed as 268,505,751. By signing, the seller represents they do not possess undisclosed material adverse information about the issuer.
Danielle L. Kirgan, EVP & Chief HR Officer of Macy's, Inc. (M), reported an insider sale of 50,000 shares on 09/11/2025 at $17.50 per share. After the sale she beneficially owns 236,161 shares reported as direct ownership. The Form 4 shows no derivative transactions and was signed by an attorney-in-fact on 09/12/2025.
Macy’s, Inc. filed an amended quarterly report for the period ended August 2, 2025. The amendment is limited to correcting the name of the Company’s Chief Financial Officer in the CFO certifications attached as Exhibits 31.2 and 32.2.
No other part of the original quarterly report has been changed, and the amendment does not update or modify any prior disclosures. The company confirms its large accelerated filer status and notes that 268,505,751 shares of common stock were outstanding as of August 30, 2025.
Paul Griscom, SVP and Controller of Macy's, Inc. (M), reported a sale of 12,843 shares of Macy's common stock on 09/11/2025 at an average price of $17.2601 per share. After the sale, Mr. Griscom beneficially owned 23,379 shares. The Form 4 was signed by an attorney-in-fact, indicating the filing was made under power of attorney.
Macy's, Inc. notice of proposed sale reports an intended sale of 12,843 shares of common stock through Charles Schwab on 09/11/2025 with an aggregate market value of $218,844.72. The filing shows total shares outstanding of 268,505,751, and the shares to be sold were acquired via restricted stock vesting and performance vesting between 09/04/2023 and 09/04/2024 from Macy's as compensation. The filer reports no securities sold in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Macy's, Inc. (M) Form 144 notifies the proposed sale of 100,000 shares of common stock to be executed through Charles Schwab on 09/10/2025 with an aggregate market value listed at $1,721,000.00 and 268,505,751 shares outstanding. The filing lists a series of restricted and performance-based stock vestings from 03/21/2024 through 03/31/2025 that together account for the securities to be sold, and indicates the shares were received as compensation. The seller is identified as Danielle L. Kirgan with a prior sale on 09/05/2025 of 100,000 shares generating gross proceeds of $1,729,527.03. The notice includes the signer’s representation that no undisclosed material adverse information is known.
Macy's, Inc. quarterly report describes operating and financing activity through the 13 and 26 weeks ended August 2, 2025. The company details its omni-channel operations under Macy's, Bloomingdale's and Bluemercury and reports ongoing execution of its "A Bold New Chapter" strategy, including the Reimagine 125 store initiative that outperformed the fleet. Digital sales comprised ~31%–32% of net sales in the periods presented. The company changed inventory valuation in February 2024 to LIFO cost method and did not restate prior periods. It completed a $500 million private offering of 7.375% notes due 2033, used proceeds to fund tenders and redemptions totaling $587 million and recorded a $13 million extinguishment loss. The ABL facility was amended and extended to $2.1 billion maturing April 2030. Share repurchases totaled ~12.6 million shares for ~$151 million year-to-date. The filing highlights supply-chain, tariff and macro risks and adoption timelines for new FASB ASUs.
Danielle L. Kirgan, Executive Vice President and Chief HR Officer of Macy's, Inc. (M), sold 100,000 shares of Macy's common stock on 09/05/2025 at a weighted-average price of $17.2953 per share, with transaction prices ranging from $17.25 to $17.425. After the sale, the reporting person beneficially owned 286,161 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/09/2025. The filing discloses the sale in multiple transactions and offers to provide detailed per-price quantities on request.